Summary: Creative Biolabs provides GLP-compliant in vivo test services for anti-CSPG4 CAR-T cell therapy in multiple human malignancies, especially in melanoma. CSPG4 (chondroitin sulfate proteoglycan 4), also known as human integral melanoma-associated chondroitin sulfate proteoglycan (MCSP) or neuron-glial antigen 2 (NG2), is originally identified on the surface of cutaneous melanoma cells for its namesake. Normally, it is extensively expressed in glial cells, immature cell phenotypes (precursor/progenitor cells.
Agriculture & Food
Business Services
Electronics, IT and Telecoms
Leisure & Tourism
Minerals
Textiles, Clothing, Leather,
Transport & Logistics
